Invex Therapeutics Ltd.ASX: IXC

First UK Clinical Site Activated in IIH EVOLVE Phase 3 Trial

Oct 24, 2022 at 2:42 AM UTC · Issued by Invex Therapeutics Ltd.

Invex Therapeutics Ltd has released a press release.

View Attachment